← Back to all clusters

Cluster 236

7 diseases · 15 shared-gene connections
7 Diseases
31 Unique genes
0.236 Avg. similarity score
Alpha-1 antitrypsin deficiency Most-connected disease (5 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Disease ⇵ Connections in cluster ⇵ Significant partners ⇵ Curated genes ⇵
Alpha-1 antitrypsin deficiency 5 5 1
Beriberi 5 5 1
Gastro-entero-pancreatic neuroendocrine tumor 5 5 15
Panniculitis 5 5 1
Thiamine deficiency 5 5 1
Asbestosis 4 4 17
immunodeficiency 63 with lymphoproliferation and autoimmunity 1 1 1

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
SERPINA1 6 / 7 Alpha-1 antitrypsin deficiency, Asbestosis, Beriberi, Gastro-entero-pancreatic neuroendocrine tumor and 2 more
IL2RB 2 / 7 Gastro-entero-pancreatic neuroendocrine tumor, immunodeficiency 63 with lymphoproliferation and autoimmunity
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Amoebiasis KEGG 6 / 103 22.6× 2.13e-7 1.26e-5 ✓ sig.
Lipid and atherosclerosis KEGG 7 / 216 12.6× 1.01e-6 4.90e-5 ✓ sig.
Pertussis KEGG 5 / 78 24.8× 1.51e-6 6.96e-5 ✓ sig.
Interleukin-10 signaling Reactome 4 / 47 33.0× 5.99e-6 2.20e-4 ✓ sig.
Interleukin-4 and Interleukin-13 signaling Reactome 5 / 108 17.9× 7.56e-6 2.65e-4 ✓ sig.
Inflammatory bowel disease KEGG 4 / 66 23.5× 2.34e-5 6.79e-4 ✓ sig.
ATF6 (ATF6-alpha) activates chaperones Reactome 2 / 4 194× 3.86e-5 1.03e-3 ✓ sig.
Leishmaniasis KEGG 4 / 78 19.9× 4.53e-5 1.18e-3 ✓ sig.
RUNX3 Regulates Immune Response and Cell Migration Reactome 2 / 5 155× 6.42e-5 1.56e-3 ✓ sig.
Th1 and Th2 cell differentiation KEGG 4 / 93 16.7× 9.03e-5 2.07e-3 ✓ sig.
Tuberculosis KEGG 5 / 181 10.7× 9.09e-5 2.08e-3 ✓ sig.
African trypanosomiasis KEGG 3 / 37 31.4× 1.14e-4 2.49e-3 ✓ sig.
Allograft rejection KEGG 3 / 39 29.8× 1.34e-4 2.83e-3 ✓ sig.
Chagas disease KEGG 4 / 103 15.0× 1.34e-4 2.85e-3 ✓ sig.
C-type lectin receptor signaling pathway KEGG 4 / 105 14.8× 1.45e-4 3.03e-3 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
cellular response to lipopolysaccharide GO:0071222 7 / 187 22.6× 1.93e-8 3.02e-6 ✓ sig.
positive regulation of transcription by RNA polymerase II GO:0045944 13 / 1,208 6.5× 2.22e-8 3.42e-6 ✓ sig.
positive regulation of immunoglobulin production GO:0002639 4 / 33 73.1× 2.45e-7 2.57e-5 ✓ sig.
cell redox homeostasis GO:0045454 4 / 44 54.8× 8.03e-7 6.94e-5 ✓ sig.
positive regulation of heterotypic cell-cell adhesion GO:0034116 3 / 13 139× 1.17e-6 9.40e-5 ✓ sig.
positive regulation of miRNA transcription GO:1902895 4 / 56 43.1× 2.14e-6 1.52e-4 ✓ sig.
humoral immune response GO:0006959 4 / 58 41.6× 2.47e-6 1.71e-4 ✓ sig.
chronic inflammatory response to antigenic stimulus GO:0002439 2 / 2 603× 2.66e-6 1.81e-4 ✓ sig.
positive regulation of DNA-templated transcription GO:0045893 9 / 778 7.0× 3.17e-6 2.09e-4 ✓ sig.
positive regulation of interleukin-8 production GO:0032757 4 / 65 37.1× 3.91e-6 2.47e-4 ✓ sig.
positive regulation of non-canonical NF-kappaB signal transduction GO:1901224 4 / 66 36.5× 4.16e-6 2.59e-4 ✓ sig.
response to lipopolysaccharide GO:0032496 5 / 161 18.7× 6.32e-6 3.62e-4 ✓ sig.
regulation of ATF6-mediated unfolded protein response GO:1903891 2 / 3 402× 7.98e-6 4.37e-4 ✓ sig.
positive regulation of T cell mediated immunity GO:0002711 2 / 3 402× 7.98e-6 4.37e-4 ✓ sig.
positive regulation of cytokine production GO:0001819 4 / 81 29.8× 9.43e-6 4.99e-4 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Alpha-1 antitrypsin deficiency Beriberi 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Alpha-1 antitrypsin deficiency Panniculitis 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Alpha-1 antitrypsin deficiency Thiamine deficiency 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Beriberi Panniculitis 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Beriberi Thiamine deficiency 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Panniculitis Thiamine deficiency 0.500 1 6.49e-5 2.34e-4 ✓ sig.
Alpha-1 antitrypsin deficiency Gastro-entero-pancreatic neuroendocrine tumor 0.063 1 9.74e-4 1.64e-3 ✓ sig.
Beriberi Gastro-entero-pancreatic neuroendocrine tumor 0.063 1 9.74e-4 1.64e-3 ✓ sig.
Gastro-entero-pancreatic neuroendocrine tumor Panniculitis 0.063 1 9.74e-4 1.64e-3 ✓ sig.
Gastro-entero-pancreatic neuroendocrine tumor immunodeficiency 63 with lymphoproliferation and autoimmunity 0.063 1 9.74e-4 1.64e-3 ✓ sig.
Gastro-entero-pancreatic neuroendocrine tumor Thiamine deficiency 0.063 1 9.74e-4 1.64e-3 ✓ sig.
Alpha-1 antitrypsin deficiency Asbestosis 0.056 1 1.10e-3 1.81e-3 ✓ sig.
Asbestosis Beriberi 0.056 1 1.10e-3 1.81e-3 ✓ sig.
Asbestosis Panniculitis 0.056 1 1.10e-3 1.81e-3 ✓ sig.
Asbestosis Thiamine deficiency 0.056 1 1.10e-3 1.81e-3 ✓ sig.